Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLE letrozole extension study in postmenopausal breast cancer
ISRCTN43286545Phase 3Completed
- Sponsor
- European Institute of Oncology
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of letrozole in breast cancer (2 arms), sponsored by European Institute of Oncology. Primary endpoint: Disease-free survival. Started Nov 2007; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN43286545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN43286545.